February 13, 2026

Emergent BioSolutions Inc. (EBS) Stock Analysis: A 24% Potential Upside Amid Strategic Healthcare Solutions

Emergent BioSolutions Inc. (NYSE: EBS) stands out in the healthcare sector, particularly among specialty and generic drug manufacturers. With a market capitalization of approximately $578.86 million, the company has carved..

LENZ Therapeutics (LENZ) Stock Analysis: Eyeing a 295% Upside in the Biotech Arena

LENZ Therapeutics, Inc. (NASDAQ: LENZ), a pioneering player in the biotechnology sector, has been gaining attention for its bold venture into presbyopia treatment—a common vision condition affecting millions globally. With..

AngioDynamics, Inc. (ANGO): Exploring a 75% Potential Upside and Analyst Confidence

AngioDynamics, Inc. (ANGO), a prominent player in the healthcare sector, specializes in medical instruments and supplies that cater to the treatment of peripheral vascular diseases, oncology, and various surgical settings...

Oruka Therapeutics, Inc. (ORKA) Stock Analysis: Promising 70% Upside Potential in Biotech

Oruka Therapeutics, Inc. (NASDAQ: ORKA) is emerging as a noteworthy player in the biotechnology sector, captivating investors with its focus on innovative monoclonal antibody therapeutics aimed at tackling psoriasis and..

Claritev Corporation (CTEV) Stock Analysis: Discovering a 186% Potential Upside in Healthcare Innovation

Claritev Corporation (NYSE: CTEV), a key player in the healthcare information services industry, presents a compelling opportunity for investors with its innovative data analytics and technology-enabled solutions. Despite recent challenges,..

Kamada Ltd. (KMDA) Stock Analysis: Unveiling a 51.69% Potential Upside in Healthcare Investments

For investors seeking opportunities in the healthcare sector, Kamada Ltd. (NASDAQ: KMDA) presents a compelling case with its significant potential upside of 51.69%. This Israeli-based company, with a market capitalization..

LifeMD, Inc. (LFMD) Stock Analysis: Exploring a 230% Potential Upside in the Healthcare Sector

LifeMD, Inc. (NASDAQ: LFMD) is making waves in the healthcare sector as a direct-to-patient telehealth company with a diverse portfolio of services and substantial potential upside for investors. With a..

Treace Medical Concepts, Inc. (TMCI) Stock Analysis: Navigating a Potential 121% Upside in the Healthcare Sector

Treace Medical Concepts, Inc. (NASDAQ: TMCI), a company operating within the healthcare sector and specializing in medical devices, presents a fascinating opportunity for investors with its current market dynamics. Based..

Tectonic Therapeutic, Inc. (TECX) Stock Analysis: Exploring a Potential 249% Upside with Cutting-Edge Biotech Innovations

Tectonic Therapeutic, Inc. (NASDAQ: TECX), a promising player in the biotechnology sector, is capturing investor attention with its innovative approach to therapeutic protein and antibody development. With a market capitalization..

Verastem, Inc. (VSTM) Investor Outlook: Unveiling a Potential 184.67% Upside in Biotech

In the dynamic world of biotechnology, Verastem, Inc. (NASDAQ: VSTM) has emerged as a compelling story for investors seeking high-growth opportunities. With its current focus on breakthrough cancer treatments, this..

Phibro Animal Health Corporation (PAHC) Stock Analysis: Evaluating Growth Amidst Market Fluctuations

Phibro Animal Health Corporation (NASDAQ: PAHC), a prominent player in the healthcare sector, has been capturing investor interest with its robust revenue growth and strategic positioning in the animal health..

Bicara Therapeutics Inc. (BCAX) Investor Outlook: Exploring a 108% Upside Potential in the Biotech Arena

Investors with a keen interest in the healthcare sector might find Bicara Therapeutics Inc. (NASDAQ: BCAX) a compelling opportunity, particularly given its significant upside potential of 108.20%, according to analyst..

Tyra Biosciences, Inc. (TYRA) Stock Analysis: Exploring a 55% Upside in the Biotech Sector

Tyra Biosciences, Inc. (NASDAQ: TYRA), a burgeoning name in the biotechnology sector, has captured investor attention with its ambitious pipeline and a robust potential upside of 55.16%. This California-based company,..

Definitive Healthcare Corp. (DH) Investor Outlook: Navigating a 153% Potential Upside Amidst Market Challenges

Definitive Healthcare Corp. (NASDAQ: DH), a key player in the health information services sector, stands out with its ambitious potential upside of 153.65%. Despite recent challenges, this U.S.-based company, headquartered..

Delcath Systems, Inc. (DCTH) Stock Analysis: Exploring a Compelling 144.88% Upside Potential

Delcath Systems, Inc. (NASDAQ: DCTH), a prominent player in the healthcare sector’s medical devices industry, is capturing investor attention with its significant upside potential and innovative cancer treatment solutions. With..

Upstream Bio, Inc. (UPB) Stock Analysis: Unveiling a Potential 271.65% Upside in the Biotech Sector

Upstream Bio, Inc. (UPB), a burgeoning player in the biotechnology sector, is capturing investor attention with its promising portfolio in the healthcare domain, specifically targeting severe respiratory disorders. Headquartered in..

CareDx, Inc. (CDNA) Stock Analysis: Unpacking the 15.18% Potential Upside for Investors

CareDx, Inc. (CDNA), a key player in the healthcare sector, specializes in diagnostics and research with a focus on providing innovative solutions for transplant patients. Headquartered in Brisbane, California, CareDx..

Prothena Corporation plc (PRTA) Stock Analysis: Exploring a 129.76% Potential Upside in Biotechnology

Prothena Corporation plc (NASDAQ: PRTA) presents a compelling opportunity in the biotechnology sector, boasting a market capitalization of $476.4 million and a robust product pipeline aimed at addressing complex neurological..

KalVista Pharmaceuticals (KALV) Stock Analysis: Unpacking a 123% Potential Upside

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) is making waves in the biotechnology sector, drawing significant attention from investors with its promising pipeline and remarkable potential upside. With a market capitalization of..

Tilray Brands, Inc. (TLRY) Stock Analysis: Exploring a 57.88% Potential Upside Amidst Market Challenges

Tilray Brands, Inc. (TLRY), a Canadian-based lifestyle consumer products company, has garnered significant attention in the healthcare sector, particularly within the drug manufacturers’ industry. With a diverse portfolio that encompasses..

Search

Funds

February 13, 2026

Search

Funds

February 13, 2026

FTSE 100

Funds